Temozolomide 75834-0145
Product NDC
75834-0145- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 7, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA213328
Need to source Temozolomide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Temozolomide | 180 mg/1 |
Drug Class
Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]
Packaging Options(2)
1 CARTON in 1 CARTON (75834-145-05) / 5 CAPSULE in 1 CARTON
1 CARTON in 1 CARTON (75834-145-14) / 14 CAPSULE in 1 CARTON